
    
      Medication, Dose and Method for Administration:

        -  Rituximab: 375 mg/m2, endovenous, according to the protocol of the service, day 1
           (except in the first cycle, in which it will be on day 5).

        -  Etoposide: 50 mg/m2/day, in continuous 24-hour infusion, days 1 to 4.

        -  Adriamycin: 10 mg/m2/day, in continuous 24-hour infusion of, days 1 to 4.

        -  Vincristine: 0.4 mg/m2/day, in continuous 24-hour infusion, days 1 to 4

        -  Dexamethasone: 40 mg, endovenous, days 1 to 5. Followed by prednisone 30 mg (day +6), 20
           mg (day +7), and 10 mg (day +8).

        -  Cyclophosphamide: 750 mg/m2, endovenous, in 30 minutes, day 5, after ending the
           continuous infusion of adriamycin, etoposide and vincristine.

        -  MESNA (If the dose of Cyclophosphamide is > 1 g/m2
    
  